Most Recent Articles about PACB
https://www.zacks.com/stock/news/2240028/pacbio-s-pacb-new-panel-to-aid-its-clinical-research-solution?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240028
Mar 13, 2024 - PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
zc:3995138679419562163
0
https://www.zacks.com/stock/news/2227228/pacific-biosciences-pacb-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2227228
Feb 15, 2024 - While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:4407130131563038335
0
https://www.zacks.com/stock/news/2227162/pacific-biosciences-of-california-pacb-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2227162
Feb 15, 2024 - Pacific Biosciences (PACB) delivered earnings and revenue surprises of 12.90% and 0.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:864390759263009185
0